Column Group L P
SEC-identified person · CIK 1347769 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| NGM Biopharmaceuticals INC NGM | Director | filed 2019 - 2024 |
| Nurix Therapeutics, Inc. NRIX | Officer | filed 2020 - 2021 |
| Constellation Pharmaceuticals INC CNST | Officer | filed 2018 - 2021 |
| Immune Design Corp. IMDZ | Officer | filed 2014 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.